Protective effect of Clerodendron glandulosum extract against experimentally induced metabolic syndrome in rats

Pharmaceutical Biology

Volumn 48, Issue 12, 2010, Pages 1312-1319

  Jadeja, Ravirajsinh N ^a   Thounaojam, Menaka C ^a   Ansarullah, ^a   Patel, Vaibhav B ^a   Devkar, Ranjitsinh V ^a   Ramachandran, A V ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Charles foster rats; Clerodendron glandulosum aqueous extract; Dyslipidemia; Insulin resistance; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CLERODENDRON GLANDULOSUM EXTRACT; FATTY ACID; FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; PLANT EXTRACT; PROTECTIVE AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLERODENDRON GLANDULOSUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DYSLIPIDEMIA; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIVER WEIGHT; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT LEAF; RAT; TRIACYLGLYCEROL BLOOD LEVEL; VASOCONSTRICTION; VASODILATATION; VERBENACEAE; WEIGHT CHANGE;

ANIMALS; BLOOD PRESSURE; CLERODENDRUM; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; METFORMIN; PLANT EXTRACTS; PLANT LEAVES; RATS; VASOCONSTRICTION; VASODILATION;

CLERODENDRUM; RATTUS; VERBENACEAE;

EID: 78649342759     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880201003739304     Document Type: Article

References (44)

1. Ahren B, Pacini G (2004): Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Euro J Endocrinol 150: 97-104.
2. Amos S, Akah PA, Binda L, Enwerem NM, Ogundaini A, Wambebe C, Hussaini IM, Gamaniel KS (2003): Hypotensive activity of the ethanol extract of Pavetta crassipes leaves. Biol Pharm Bull 26: 1674-1680.
3. Ansarullah, Tounaojam M, Jadeja R, Devkar R, Ramachandran AV (2009): Oreocnide integrifolia (Gaud.) Miq. exhibits hypoglycemic and hypolipidemic potentials on streptozotocin diabetic rats: A preliminary dose and duration dependent study. EXCLI J 8: 97-106.
4. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS (2002): Antidiabetic efects of Panax ginseng berry extract and the identifcation of an efective component. Diabetes 51: 1851-1858.
5. Bakris G, Sowers J, Epstein M, Williams M (2000): Hypertension in patients with diabetes. Why is aggressive treatment essential? Postgrad Med J 107: 53-61.
6. Balaraman R, Dangwal S, Mohan M (2006): Antihypertensive efect of Trigonella foenum-greacum seeds in experimentally induced hypertension in rats. Pharm Biol 44: 568-575.
7. Basciano H, Federico L, Adeli K (2005): Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & Metabolism 2: 5.
8. Calixto JB (2000): Efcacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 33:179-189.
9. Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi LA (2003): Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens: 16: 973-978.
10. Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB (2004): Independent and additive efects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr 80: 308-316.
11. Cummings LE (1988): Commercial foodservice considerations in providing consumer-driven nutrition program elements. Part I. Consumer health objectives and associated employee education needs. Catering & Health 1: 51-71.
12. Dai S, McNeill JH (1995): Fructose-induced hypertension in rats is concentration-and duration-dependent. J Pharmacol Toxicol Meth 33: 101-107.
13. Deb S, Arunachalam A, Das AK (2009): Indigenous knowledge of Nyishi tribes on traditional agroforestry systems. Indian J Trad Knowledge 8: 41-46.
14. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J (1995): A simple measure of insulin resistance. Lancet 346: 120-121.
15. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE (2002): Te rising prevalence of diabetes and impaired glucose tolerance. Te Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25: 829-834.
16. Edwards KL, Talmud PJ, Newman B, Krauss RM, Austin MA (2001): Lipoprotein candidate genes for multivariate factors of the insulin resistance syndrome: A sib-pair linkage analysis in women twins. Twin Res 4: 41-47.
17. Fineberg SE (1999): Te treatment of hypertension and dyslipidemia in diabetes mellitus. Prim Care 26: 951-964.
18. Friedewald W T, Levy RI, Fredrickson DS (1972): Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
19. Granberry MC, Hawkins JB, Franks AM (2007): Tiazolidinediones in patients with type 2 diabetes mellitus and heart failure. Am J Health Syst Pharm 64: 931-936.
20. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC (2004): Defnition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientifc Issues Related to Defnition. Circulation 109: 433-438.
21. Grundy SM (2006): Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clinical Cornerstone 8: 21-27.
22. Hwang IS, Ho H, Hofman BB, Reaven GM (1987): Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516.
23. IDF (2006): Diabetes atlas, third edition. Brussels, Belgium: International Diabetes Federation.
24. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L (2001): Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
25. Itaya K, Ui M (1965): Colorimetric determination of free fatty acids in biological fuids. J Lipid Res 6: 16-20.
26. Jadeja R, Tounaojam M, Ansarullah, Ramachandran AV, Devkar R (2009a): Phytochemical constituents and free radical scavenging activity of Clerodendron glandulosum Coleb methanolic extract. J Compl Integr Med 1: 19.
27. Jadeja RN, Tounaojam MC, Ansarullah, Devkar RV, Ramachandran AV (2009b): A preliminary study on hypolipidemic efect of aqueous leaf extractof Clerodendron glandulosum Coleb. Int J Green Pharm 3: 285-289.
28. Kala CP (2005): Ethnomedicinal botany of the Apatani in the eastern Himalayan region of India. J Ethnobiol Ethnomed 1: 11.
29. Karpe F, Tan GD (2005): Adipose tissue functions in the insulin-resistance syndrome. Biochem Soc Trans 33: 1045-1048.
30. Le KA, Tappy L (2006): Metabolic efects of fructose. Curr Opin Clin Nutr Metab Care 9: 469-475.
31. Liou SS, Liu IM, Hsu JH, Wu YC, Hsu SF, Chen JT (2002): Release of acetylcholine by Die-Huang-Wan to enhance insulin secretion for lowering plasma glucose in Wistar rats. Auton Neurosci 100: 21-26.
32. Mayes GL, Allan G, Azhar S (2004): High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregu-lation. Endocrinology 145: 548-555.
33. Mayes PA (1993): Intermediary metabolism of fructose. Am J Clin Nutr 58:754-765.
34. Ramin A, Willliam J, Pisit P (1996): Antiobesity efect of diazoxide in obese Zucker rats. Metabolism 45: 334-341.
35. Reaven GM (1988): Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
36. Rosen P, Ohly P, Gleichmann H (1997): Experimental beneft of moxo-nidine on glucose metabolism and insulin secretion in the fructose-fed rat. J Hypertens 15: 31-38.
37. Stern M, Williams K, Gonzalez-Villalpando C (2004): Does the metabolic syndrome improve identifcation of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27: 2676-2681.
38. Tounaojam M, Jadeja R, Ansarullah, Devkar R, Ramachandran AV (2009): Dysregulation of lipid and cholesterol metabolism in high fat diet fed hyperlipidemic rats: Protective efect of Sida rhomboi-dea Roxb leaf extract. J Health Sci 55: 413-420.
39. Valiathian MS (1998): Healing plants. Cur Sci 75: 1122-1126.
40. WHO (2002): Launches the frst global strategy on traditional and alternative medicine. WHO press release 38, p. 2. Geneva, World Health Organization.
41. Willett WC (2002): Dietary fat plays a major role in obesity. Obesity Reviews 3: 59-68.
42. Yokozawa T, Kim HJ, Yamabe N, Okamoto T, Cho EJ (2007): Te protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model. J Pharm Pharmacol 59: 1271-1278.
43. Zammit VA, Waterman IJ, Topping D, McKay G (2001): Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131: 2074-2077.
44. Zavaroni I, Chen YD, Reaven GM (1982): Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat. Metabolism 31: 1077-1083.